Norlevo (Levonorgestrel)

Levonorgestrel acts primarily by binding to progesterone receptors, which suppresses the luteinizing hormone surge and delays or inhibits ovulation. If ovulation has already occurred, it can alter tubal motility and the endometrial lining, reducing the chance of fertilization and implantation of a fertilized egg.

The specific dose of Norlevo is determined by the prescribing healthcare professional or the product label. In most jurisdictions the medication is supplied as a single oral tablet that should be taken as soon as possible after the relevant sexual exposure.

Norlevo is not intended for use during an established pregnancy and will not terminate an existing pregnancy. Limited data suggest that occasional use of levonorgestrel does not pose a significant risk to breastfeeding infants, but women should discuss any concerns with their healthcare provider.

To request Norlevo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any required import documentation.

The primary alternative is ulipristal acetate (e.g., Ella). Ulipristal can be effective up to 120 hours after intercourse, whereas levonorgestrel‑based products like Norlevo are recommended within 72 hours. Levonorgestrel is generally less expensive and available over the counter in many regions, while ulipristal often requires a prescription.

Norlevo tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Norlevo is taken as a single oral tablet. The tablet should be swallowed whole with water as soon as possible after unprotected intercourse, ideally within 72 hours. No food restrictions are required, but taking the tablet with a full glass of water may aid absorption.

Serious but rare risks include severe allergic reactions such as rash, swelling, or difficulty breathing, persistent or heavy vaginal bleeding, and intense abdominal pain or vomiting. If any of these occur, medical attention should be sought immediately.

Norlevo should be avoided by individuals with a known hypersensitivity to levonorgestrel or any tablet excipients. Women who are already pregnant, have severe liver disease, or have a history of thromboembolic disorders should consult a healthcare professional before use.